Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review

Summary

Abbott Laboratories (Abbott) is a global healthcare company. It undertakes the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products including pharmaceuticals, diagnostics, vascular and nutritional products. The company’s pharmaceutical, medical, and nutritional products include a wide range of specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; a range of nutritional supplements for infants, children and adults; and products for veterinary care. Its research and development, manufacturing and administrative facilities are spread across the world.

Abbott Laboratories Key Recent Developments

Feb 21, 2013: Abbott Plans To Eliminate 200 Jobs From Plant In Ireland
Feb 08, 2013: Abbott India To Start Commercial Production At Jhagadia, Gujarat
Jan 23, 2013: Abbott Reports Revenue Of $10.8 Billion In Q4 2012
Jan 02, 2013: Abbott Completes Separation Of Research-Based Pharmaceuticals Business
Dec 18, 2012: Abbott Labs Contract Pharmaceutical Manufacturing Expands Potent Capability With Advanced Granulation Roller CompactorGDME1255FSA

This comprehensive SWOT profile of Abbott Laboratories provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

List of Tables
List of Figures
Section 1 - About the Company
Abbott Laboratories - Key Facts
Abbott Laboratories - Key Employees
Abbott Laboratories - Key Employee Biographies
Abbott Laboratories - Major Products and Services
Abbott Laboratories - History
Abbott Laboratories - Company Statement
Abbott Laboratories - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Abbott Laboratories - Key Manufacturing Facilities
Section 2 – Company Analysis
Abbott Laboratories - Business Description
Business Description - Diagnostics
Diagnostics - Overview
Diagnostics - Financials
Business Description - Established Pharmaceutical Products
Established Pharmaceutical Products - Overview
Established Pharmaceutical Products - Financials
Business Description - Nutritionals
Nutritionals - Overview
Nutritionals - Financials
Nutritionals - Market View
Business Description - Proprietary Pharmaceutical Products
Proprietary Pharmaceutical Products - Overview
Proprietary Pharmaceutical Products - Financials
Business Description - Vascular
Vascular - Overview
Vascular - Financials
Abbott Laboratories - Corporate Strategy
Abbott Laboratories - SWOT Analysis
SWOT Analysis - Overview
Abbott Laboratories - Strengths
Strength - Diversified Business Operations
Strength - Geographical Diversity
Strength - Constant Growth in Revenues
Abbott Laboratories - Weaknesses
Weakness - Legal Proceedings
Weakness - Product Recalls
Abbott Laboratories - Opportunities
Opportunity - Changing Demographics
Opportunity - Regulatory Approvals
Opportunity - Industry Recognitions
Abbott Laboratories - Threats
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
Threat - Stringent Government Regulations
Threat - Rapid Technological Changes
Abbott Laboratories - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals By Type, 2007 to YTD 2013
Abbott Laboratories, Recent Deals Summary
Section 5 – Company’s Recent Developments
Abbott Laboratories, Recent Developments
Mar 10, 2013: Abbott's Minimally Invasive MitraClip System For Mitral Regurgitation Demonstrates Positive Clinical And Quality-Of-Life Results For Patients Too High Risk For Surgery
Feb 21, 2013: Abbott Plans To Eliminate 200 Jobs From Plant In Ireland
Feb 21, 2013: Abbott Vascular Cuts 450 Jobs At Its Temecula Plant
Jan 23, 2013: Abbott Reports Revenue Of $10.8 Billion In Q4 2012
Jan 09, 2013: Abbott Receives CE Mark For Architect Stat High Sensitive Troponin-I Assay
Jan 03, 2013: Abbott Announces FDA Approval And US Launch Of Next-Generation Xience Xpedition Drug Eluting Stent System
Dec 18, 2012: Abbott Labs Contract Pharmaceutical Manufacturing Expands Potent Capability With Advanced Granulation Roller Compactor
Dec 17, 2012: Abbott Receives FDA Clearance For Architect Second Generation Testosterone Assay
Dec 13, 2012: New Study Shows Promising Results For Tests That Can Help Doctors Better Evaluate Potential Heart Attacks: Abbott
Dec 07, 2012: Abbott Expects To Complete Separation Of AbbVie On January 1, 2013
Section 6 – Appendix
Methodology
Ratio Definitions
About Us
Contact Us
Disclaimer

List of Tables
Abbott Laboratories, Key Facts
Abbott Laboratories, Key Employees
Abbott Laboratories, Key Employee Biographies
Abbott Laboratories, Major Products and Services
Abbott Laboratories, History
Abbott Laboratories, Other Locations
Abbott Laboratories, Subsidiaries
Abbott Laboratories, Key Manufacturing Facilities
Abbott Laboratories, Key Competitors
Abbott Laboratories, Ratios based on current share price
Abbott Laboratories, Annual Ratios
Abbott Laboratories, Interim Ratios
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals By Type, 2007 to YTD 2013
Abbott Laboratories, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Abbott Laboratories, Performance Chart (2008 - 2012)
Abbott Laboratories, Ratio Charts
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals By Year, 2007 to YTD 2013
Abbott Laboratories, Medical Equipment, Deals by Type, 2007 to YTD 2013

GlaxoSmithKline
Bayer HealthCare AG
Boehringer Ingelheim GmbH
Eli Lilly and Company
Becton, Dickinson and Company
Siemens Healthcare
Edwards Lifesciences Corporation
Medtronic, Inc.
F. Hoffmann-La Roche Ltd.
Cordis Corporation
Boston Scientific Corporation
Beckman Coulter, Inc.

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.